99mTc-P215(Merck & Co Inc)

N/A

Report date: 2025/11/24 17:27:58

NME

Base Information

Drug Name99mTc-P215(Merck & Co Inc)

Drug Alias Name99mTc-LDL99mTc-P215P215 Techtidetechnetium-99m P215

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTcDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5]

Mechanisms of ActionProstate-Specific Membrane Antigen inhibitorsPositron-emission tomography enhancers

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMerck & Co Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMerck Sharp & Dohme Corp

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A